Who owns ACASTI PHARMA INC?
- Ticker: GRCE
- CUSIP Number: 00439u104
Tip: Access positions for across all investors
Analyze quarterly positions in Acasti Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acasti Pharma stock
Who bought or sold ACASTI PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 1.2M | $4.1M | 0% | Dec 2025 |
|
| ADAR1 Capital Management | 642k | $2.2M | 83% | Dec 2025 |
|
| Vanguard Group | 424k | $1.5M | 4% | Dec 2025 |
|
| HPM Partners | 423k | $1.5M | 100% | Dec 2025 |
|
| Vanguard Capital Management | 402k | $1.9M | 100% | Mar 2026 |
|
| Jane Street | 167k | $774k | 100% | Mar 2026 |
|
| Renaissance Technologies | 130k | $449k | 53% | Dec 2025 |
|
| Connective Capital Management | 85k | $392k | 100% | Mar 2026 |
|
| Citadel Advisors | 42k | $148k | 55% | Dec 2025 |
|
| XTX Topco | 30k | $106k | 100% | Dec 2025 |
|
| UBS Group | 26k | $122k | 100% | Mar 2026 |
|
| Kestra Private Wealth Services | 13k | $60k | 100% | Mar 2026 |
|
| Oppenheimer & Co | 10k | $46k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 8.8k | $41k | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 7.1k | $33k | 1083% | Mar 2026 |
|
| Group One Trading | 5.0k | $23k | 100% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 2.7k | $9.4k | 0% | Dec 2025 |
|
| Tower Research Capital | 1.9k | $6.7k | 21% | Dec 2025 |
|
| Wells Fargo & Company | 1.8k | $8.3k | 100% | Mar 2026 |
|
| SRS Capital Advisors | 500.00 | $2.3k | 100% | Mar 2026 |
|
| Activest Wealth Management | 104.00 | $481.998400 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 82.00 | $379.996200 | 100% | Mar 2026 |
|
| SBI Securities | 70.00 | $324.002000 | -31% | Mar 2026 |
|
| Steward Partners Investment Advisory | 41.00 | $189.998100 | 0% | Mar 2026 |
|
| Nbc Securities | 2.00 | $9.000000 | 0% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 1.00 | $5.000000 | 0% | Mar 2026 |
|
Who sold out of Acasti Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| AIGH Capital Management | Dec 2025 | 907k | $3.2M |
| Stonepine Capital Management | Sep 2025 | 211k | $628k |
| GSA Capital Partners | Dec 2025 | 14k | $48k |
| Stratos Wealth Partners | Dec 2025 | 11k | $39k |
| Flagship Harbor Advisors | Dec 2025 | 2.00 | $7.000000 |